ZICCUM AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.14 SEK | -1.15% |
|
-9.19% | -32.90% |
| 04-29 | Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-14 | Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZICCUM AB | Biopharmaceuticals | -1.15% | -9.19% | -32.90% | -7.55% | -62.07% | 7.6M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- ZICC Stock
- Charts Ziccum AB
- Comparison Chart
